In a 19‑year‑old female with a three‑month history of progressive right‑temporal headache aggravated by coughing, cold exposure, bright light, and fan airflow, now accompanied by right‑sided painful ophthalmoplegia (intermittent diplopia that resolves when one eye is covered, medial deviation of the right eye, right upper‑eyelid ptosis, and retro‑orbital pain) and no fever or other systemic signs, what is the most likely diagnosis and what urgent investigations and initial management are recommended?

Painful Ophthalmoplegia with Progressive Headache: Tolosa-Hunt Syndrome vs. Cavernous Sinus Pathology

This 19-year-old female presents with a classic triad of progressive unilateral headache, painful ophthalmoplegia (right eye medial deviation, ptosis, diplopia resolving with monocular occlusion), and retro-orbital pain—this constellation strongly suggests Tolosa-Hunt syndrome or another cavernous sinus/superior orbital fissure lesion, and requires urgent contrast-enhanced MRI of the brain and orbits with dedicated views of the cavernous sinus to exclude mass lesions, vascular malformations, or thrombosis.

Why This Is NOT a Primary Headache Disorder

• The presence of focal neurological deficits (ophthalmoplegia, ptosis, eye deviation) immediately excludes primary headache syndromes and mandates urgent neuroimaging 1
• While cough can aggravate headache in benign cough headache, that diagnosis requires absence of any intracranial disorder and no accompanying neurological manifestations 2, 3, 4
• The progressive nature over three months with evolving cranial nerve involvement indicates a structural or inflammatory process requiring immediate investigation 5

Differential Diagnosis: Cavernous Sinus Region Pathology

Most Likely: Tolosa-Hunt Syndrome

• Painful ophthalmoplegia affecting cranial nerves III, IV, and/or VI (explaining the medial eye deviation, ptosis, and diplopia) with retro-orbital pain is the hallmark presentation
• Typically affects young to middle-aged adults and can present with gradual onset over weeks
• Requires exclusion of other cavernous sinus pathology before diagnosis

Critical Alternative: Cavernous Sinus Thrombosis

• The American Heart Association emphasizes that cerebral venous thrombosis presents with progressive headache accompanied by signs of increased intracranial pressure such as papilledema or diplopia 6
• Diplopia occurs in cerebral venous thrombosis and can be a presenting feature 1
• Headache is present in almost 90% of cerebral venous thrombosis cases and can be the only manifestation in up to 25% 6
• The three-month progressive course with focal cranial nerve deficits fits the subacute presentation pattern (48 hours to 30 days or longer) described for venous thrombosis 1

Other Considerations

• Cavernous sinus meningioma or other mass lesions
• Pituitary apoplexy (though typically more acute)
• Inflammatory conditions (sarcoidosis, granulomatosis with polyangiitis)
• Carotid-cavernous fistula

Urgent Investigations Required

Immediate Neuroimaging (Within 24 Hours)

• MRI brain and orbits with and without gadolinium contrast is the preferred initial study to assess for mass lesions, hemorrhage, and inflammatory changes in the cavernous sinus region 5
• MR venography (MRV) must be included to exclude cerebral venous sinus thrombosis, as this is a critical treatable cause 6
• Dedicated thin-slice imaging through the cavernous sinus and superior orbital fissure with fat suppression sequences

Laboratory Evaluation

• Complete blood count, comprehensive metabolic panel, prothrombin time, partial thromboplastin time 6
• Erythrocyte sedimentation rate and C-reactive protein (elevated in inflammatory conditions)
• Screening for prothrombotic conditions: oral contraceptive use history, underlying inflammatory disease, infectious process 6
• Consider antiphospholipid antibodies, lupus anticoagulant if thrombosis suspected

Lumbar Puncture Considerations

• Do NOT perform lumbar puncture until imaging excludes mass effect or significant brain shift 5
• If imaging is normal and infection/inflammation suspected, opening pressure measurement is critical (elevated in >80% of cerebral venous thrombosis cases) 6
• Cerebrospinal fluid analysis for cell count, protein, glucose, cultures if infectious etiology considered

Initial Management Approach

Before Imaging Results

• Admit for urgent evaluation—this is not an outpatient workup given progressive cranial neuropathy 5
• Hold off on empiric corticosteroids until imaging excludes infection, malignancy, or thrombosis
• Symptomatic headache management with acetaminophen or NSAIDs (avoid opioids)
• Neurology and neuro-ophthalmology consultation

If Imaging Confirms Tolosa-Hunt Syndrome

• High-dose corticosteroids (prednisone 1 mg/kg/day or methylprednisolone IV) typically produce dramatic improvement within 72 hours
• Gradual taper over 6-12 weeks to prevent relapse
• Follow-up imaging in 4-6 weeks to confirm resolution of inflammatory changes

If Imaging Reveals Cavernous Sinus Thrombosis

• Immediate anticoagulation with therapeutic-dose low-molecular-weight heparin or unfractionated heparin, transitioning to warfarin or direct oral anticoagulant 6
• Treat underlying predisposing condition (infection, inflammatory disease)
• Monitor for complications including increased intracranial pressure

If Mass Lesion Identified

• Neurosurgical consultation for biopsy or resection depending on location and characteristics
• Hold corticosteroids until tissue diagnosis unless life-threatening mass effect

Key Clinical Pitfalls to Avoid

• Do not attribute this to migraine or tension-type headache despite the three-month history—the cranial nerve findings mandate structural evaluation 7
• Do not dismiss the cough-aggravation as benign cough headache—this diagnosis requires absence of intracranial abnormalities and no focal deficits 2, 3, 4
• Do not delay imaging to trial empiric treatments—progressive ophthalmoplegia is a red-flag neurological finding requiring immediate neuroimaging 5
• Do not perform lumbar puncture before imaging—mass lesions in the cavernous sinus region can cause herniation risk 5
• Do not assume idiopathic intracranial hypertension—while this patient is a young female, IIH shows normal-sized or small ventricles on imaging, not cavernous sinus pathology, and ventriculomegaly essentially excludes classic IIH 5

Prognosis and Follow-Up

• Tolosa-Hunt syndrome typically responds dramatically to corticosteroids with resolution of pain within 72 hours and gradual improvement of ophthalmoplegia over weeks
• Cavernous sinus thrombosis requires prolonged anticoagulation (3-12 months) with good outcomes if treated promptly
• Recurrence rates for Tolosa-Hunt syndrome approach 40-50%, requiring vigilance during follow-up
• Any mass lesion prognosis depends on histology and resectability